SlideShare ist ein Scribd-Unternehmen logo
1 von 20
Global Bridges Afro Region

     Lekan Ayo-Yusuf, DDS, MPH, PhD
   15th WCTOH Preconference Workshop
            March 19, 2012
Context: Weak tobacco control in
            Africa
OBJECTIVE 1


  To create and mobilize a global
network of HCPs and organizations
  dedicated to advancing effective
tobacco dependence treatment and
  advocating for effective tobacco
            control policy
Network membership

                      The following 27countries are
From a base of
14, over 360           represented:
                                                                         Tunisia

(175 trained)                                 Morocco

                                                           Algeria

members joined                                                                     Libya
                                                                                                    Egypt




over 15 months!     Cape
                    Verde
                                      Mauritania
                                                        Mali
                                                                       Niger
                                                                                   Chad             Sudan        Eritrea
                                 Senegal                                                                                   Djibouti
                                                    Burkina


via existing
                                                     Faso
                      The Gambia       Guinea
                                                                     Nigeria                                               Somalia
                                                      Ghana                                                     Ethiopia
                       Guinea-Bissau              Côte                        Central African


health networks
                                                d'Ivoire                Cameroon Republic
                            Sierra Leone
                                    Liberia             Togo Benin                                    Uganda
                                                        Equatorial      Gabon
                                                                                 Congo                      Kenya                                         Tobacco use
                                                         Guinea                       DR Congo                             Rwanda
                                                                                                                                                      prevalence estimates
through training
                                                                                                                      Burundi
                                                                                                                                      Seychelles
                                                         São Tomé                                       Tanzania                                             No Data
                                                                                                                      Malawi
                                                        and Príncipe


workshops
                                                                                                                            Comoros
                                                                                                                                                             <10%
                                                                                 Angola
                                                                                              Zambia
                                                                                                                                                            10-19%
                                                                                                       Mozambique


through RFA for
                                                                                                Zimbabwe          Madagascar
                                           Africa                                                                                                           >=20%
                                                                               Namibia Botswana
                                                                                                                                          Mauritius



ACS tobacco                                                                                South
                                                                                           Africa
                                                                                                              Swaziland



control masters
                                                                                                            Lesotho




programme
Collaborations with other
             organizations
1. National Council Against Smoking (NCAS), South
   Africa
2. Public Health Association of South Africa (PHASA)
3. Democratic Nursing Organization of South Africa
   (DENOSA)
4. Africa Tobacco Control Regional Initiative (ATCRI),
   Nigeria
5. Africa Tobacco Control Consortium (ATCC), Togo
6. Programme National de Lutte Contre les Toxicomanies
   et les Substances Toxiques (PNLCT), Democratic
   Republic of Congo
7. Framework Convention Alliance (FCA), Democratic
   Republic of Congo
8. Centre for Tobacco Control in Africa (CTCA), Uganda
Challenges - 1
 Challenging to engage all recruited
  while running training
 Networking to make GB known
  through key actors in the region and
  country
 No website activities were available
  for most part of active recruitment
  period to sustain interest from
  members
 Diversity of culture and language
OBJECTIVE 2


To provide state-of-the-art, evidence-
   based training in treatment and
    advocacy to network members
Policy & Treatment conceptual
          framework
Tobacco cessation training
                workshops
Adapted ATTUD format (Aware → knowledgeable→ Proficient):
one day of didactic teaching followed by more interactive
skills-building in counselling (motivational interviewing) on day
2
Dates                   Location                    # of participants Length of
                                                                      training (hrs)
August 16-18           Abadan, Nigeria              25                19
August 23-25           Pretoria, South Africa       29                19
September 23, 26, 27   Lagos, Nigeria               29                20
October 27-29          Lusaka, Zambia               22                20
November 7-8           Kinshasa, DRC                33                12
November 28-30         Johannesburg, South Africa   37                8
1
1
1
Challenges - 2
 Training has been face-to-face as
  there is limited technology and in-
  country capacity to kick start tobacco
  treatment.
 Trainees have expectations to have
  more training and follow-up visits by
  facilitators
 Health system is currently
  overburdened and integration of
  treatment is seen as a challenge in
  several centers.
                                           1
OBJECTIVE 3


To facilitate the implementation of
     Article 14 in every nation




                                      1
News on the advancement of Article
               14
Measures to increase demand for
treatment
–Nigeria: the National Tobacco Control Bill was passed
on the 15 March 2011 – still awaiting president’s
ascent.

–Uganda: Launch of the CTCA - a support from Gates
through the WHO

–Pilot of feasibility of treatment support to public
servants in South Africa – a partnership between the
Public Service Admin & Health ministries and major
health insurer

                                                         1
Challenges - 3
 Tobacco control is pretty much in
  infancy in the region
 Strong leadership from advocacy
  organizations and little involvement
  from health providers makes it more
  challenging.
 Treatment (A14) has not been
  prioritized due to lack of effective
  implementation of other key
  provisions of FCTC – smoke-free laws,
  taxation and health warnings.
                                          1
Challenges - 3
 Seniors at work places have not
  embraced tobacco cessation
  treatment—no champions
 Training non-medical personnel e.g.
  social workers likely to advance Tx,
  but has implication for curriculum
  design
 Lack of funding for future work to
  sustain current advances.
 Treatment is not covered by health
  insurance                              1
Conclusions
 Popularity of the training has increased, even among non-
  health care professionals involved in tobacco control policy
 An instrument to measure the progress of trained HCPs who
  offer tobacco use treatment to their patients needs to be
  developed
 Build follow-up surveys to measure commitment of HCPs a year
  after they have received training into our training plan
 Network members need to be actively engaged after their
  recruitment to retain interest
 Train only candidates who commit to sending quarterly reports
  on patient encounters.
 Spend more time in engaging network members by posting
  relevant resource materials on the Global Bridges website and
  listserv

                                                                  1
Planned meetings
 Upcoming 2-day GB tobacco cessation
  workshops:
   –Tanzania/Kenya
   –Enugu, Nigeria
 Pre-conference workshops:
   –WFPHA; Addis Ababa, Ethiopia;
   23-27 April 2012
   –PHASA Conference; Bloemfontein,
   South Africa; 5-7 September 2012
                                        1
Acknowledgements
 Global Bridges for funding the project
 Key network partners for been
  ambassadors of GB and co-facilitating
  training
 UP, UCH,LUTH, UNZ, FCA-DRC and
  PHASA for hosting the workshops
 Network members for their valuable
  input

                                           2

Weitere ähnliche Inhalte

Ähnlich wie Challenges in Expanding the Role of Health Care Providers and Delivering Treatment in Africa -- Lekan Ayo-Yusuf, D.D.S., M.P.H., Ph.D.

African economic outlook
African economic outlookAfrican economic outlook
African economic outlookaniruddhay123
 
Ias presentation social_health_insurance_lamontagne
Ias presentation social_health_insurance_lamontagneIas presentation social_health_insurance_lamontagne
Ias presentation social_health_insurance_lamontagneUNAIDS
 
New Frontiers in NCDs_Firestone_5.1.12
New Frontiers in NCDs_Firestone_5.1.12New Frontiers in NCDs_Firestone_5.1.12
New Frontiers in NCDs_Firestone_5.1.12CORE Group
 
HIV and Vulnerability
HIV and VulnerabilityHIV and Vulnerability
HIV and VulnerabilityRENEWAL-IFPRI
 
Telecom Infrastructure in Africa
Telecom Infrastructure in AfricaTelecom Infrastructure in Africa
Telecom Infrastructure in AfricaAlain Nkoyock
 
Nestlé in CWAR winning in the new reality
Nestlé in CWAR  winning in the new realityNestlé in CWAR  winning in the new reality
Nestlé in CWAR winning in the new realityNestlé SA
 
Kondwani Mtalimanja, IT Manager at Save the Children - Current IT situation ...
Kondwani Mtalimanja, IT Manager at Save the Children  - Current IT situation ...Kondwani Mtalimanja, IT Manager at Save the Children  - Current IT situation ...
Kondwani Mtalimanja, IT Manager at Save the Children - Current IT situation ...Global Business Events
 

Ähnlich wie Challenges in Expanding the Role of Health Care Providers and Delivering Treatment in Africa -- Lekan Ayo-Yusuf, D.D.S., M.P.H., Ph.D. (10)

African economic outlook
African economic outlookAfrican economic outlook
African economic outlook
 
Ias presentation social_health_insurance_lamontagne
Ias presentation social_health_insurance_lamontagneIas presentation social_health_insurance_lamontagne
Ias presentation social_health_insurance_lamontagne
 
Complying with the Maputo Declaration: progress and implications for pursui...
Complying with the Maputo Declaration:progress and implications for pursui...Complying with the Maputo Declaration:progress and implications for pursui...
Complying with the Maputo Declaration: progress and implications for pursui...
 
Intergenerational aspects of inequality
Intergenerational aspects of inequalityIntergenerational aspects of inequality
Intergenerational aspects of inequality
 
The role of re sakss in monitoring agric trends in southern africa
The role of re sakss in monitoring agric trends in southern africaThe role of re sakss in monitoring agric trends in southern africa
The role of re sakss in monitoring agric trends in southern africa
 
New Frontiers in NCDs_Firestone_5.1.12
New Frontiers in NCDs_Firestone_5.1.12New Frontiers in NCDs_Firestone_5.1.12
New Frontiers in NCDs_Firestone_5.1.12
 
HIV and Vulnerability
HIV and VulnerabilityHIV and Vulnerability
HIV and Vulnerability
 
Telecom Infrastructure in Africa
Telecom Infrastructure in AfricaTelecom Infrastructure in Africa
Telecom Infrastructure in Africa
 
Nestlé in CWAR winning in the new reality
Nestlé in CWAR  winning in the new realityNestlé in CWAR  winning in the new reality
Nestlé in CWAR winning in the new reality
 
Kondwani Mtalimanja, IT Manager at Save the Children - Current IT situation ...
Kondwani Mtalimanja, IT Manager at Save the Children  - Current IT situation ...Kondwani Mtalimanja, IT Manager at Save the Children  - Current IT situation ...
Kondwani Mtalimanja, IT Manager at Save the Children - Current IT situation ...
 

Mehr von Global Bridges

How you and your project can benefits from using the Global Bridges website
How you and your project can benefits from using the Global Bridges websiteHow you and your project can benefits from using the Global Bridges website
How you and your project can benefits from using the Global Bridges websiteGlobal Bridges
 
Presentation on Tobacco Control: District Gujranwala progress and achievemen...
Presentation on Tobacco Control: District Gujranwala progress and achievemen...Presentation on Tobacco Control: District Gujranwala progress and achievemen...
Presentation on Tobacco Control: District Gujranwala progress and achievemen...Global Bridges
 
Webinar: Waterpipe use from the Middle East to Western Countries
Webinar: Waterpipe use from the Middle East to Western CountriesWebinar: Waterpipe use from the Middle East to Western Countries
Webinar: Waterpipe use from the Middle East to Western CountriesGlobal Bridges
 
Dr. Bianco: Humo de segunda mano y riesgos cardiovasculares
Dr. Bianco: Humo de segunda mano y riesgos cardiovascularesDr. Bianco: Humo de segunda mano y riesgos cardiovasculares
Dr. Bianco: Humo de segunda mano y riesgos cardiovascularesGlobal Bridges
 
Going mobile: the potential of mHealth for tobacco dependence treatment
Going mobile: the potential of mHealth for tobacco dependence treatmentGoing mobile: the potential of mHealth for tobacco dependence treatment
Going mobile: the potential of mHealth for tobacco dependence treatmentGlobal Bridges
 
WEBINAR: Secondhand Smoke: The Science and Big Tobacco's Smokescreen
WEBINAR: Secondhand Smoke: The Science and Big Tobacco's SmokescreenWEBINAR: Secondhand Smoke: The Science and Big Tobacco's Smokescreen
WEBINAR: Secondhand Smoke: The Science and Big Tobacco's SmokescreenGlobal Bridges
 
Myocardial infarction and sudden cardiac death in olmsted 10 19_11
Myocardial infarction and sudden cardiac death in olmsted 10 19_11Myocardial infarction and sudden cardiac death in olmsted 10 19_11
Myocardial infarction and sudden cardiac death in olmsted 10 19_11Global Bridges
 
Global Bridges: Pharmacotherapy for Tobacco Dependence
Global Bridges: Pharmacotherapy for Tobacco DependenceGlobal Bridges: Pharmacotherapy for Tobacco Dependence
Global Bridges: Pharmacotherapy for Tobacco DependenceGlobal Bridges
 
Global Bridges: Farmacoterapia para la dependencia del tabaco (español)
Global Bridges: Farmacoterapia para la dependencia del tabaco (español)Global Bridges: Farmacoterapia para la dependencia del tabaco (español)
Global Bridges: Farmacoterapia para la dependencia del tabaco (español)Global Bridges
 
Pharmacotherapy for Tobacco Dependence -- Richard D. Hurt, M.D., Mayo Clinic
Pharmacotherapy for Tobacco Dependence -- Richard D. Hurt, M.D., Mayo ClinicPharmacotherapy for Tobacco Dependence -- Richard D. Hurt, M.D., Mayo Clinic
Pharmacotherapy for Tobacco Dependence -- Richard D. Hurt, M.D., Mayo ClinicGlobal Bridges
 
Challenges in Expanding the Role of Health Care Providers and Delivering Trea...
Challenges in Expanding the Role of Health Care Providers and Delivering Trea...Challenges in Expanding the Role of Health Care Providers and Delivering Trea...
Challenges in Expanding the Role of Health Care Providers and Delivering Trea...Global Bridges
 
Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...
Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...
Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...Global Bridges
 
Role of Health Care Systems and Providers in Changing Tobacco Dependence Trea...
Role of Health Care Systems and Providers in Changing Tobacco Dependence Trea...Role of Health Care Systems and Providers in Changing Tobacco Dependence Trea...
Role of Health Care Systems and Providers in Changing Tobacco Dependence Trea...Global Bridges
 
Tobacco Dependence Treatment Training -- J. Taylor Hays, M.D.
Tobacco Dependence Treatment Training -- J. Taylor Hays, M.D.Tobacco Dependence Treatment Training -- J. Taylor Hays, M.D.
Tobacco Dependence Treatment Training -- J. Taylor Hays, M.D.Global Bridges
 
Overview of Tobacco Treatment Provisions at a National Level -- Martin Raw
Overview of Tobacco Treatment Provisions at a National Level -- Martin RawOverview of Tobacco Treatment Provisions at a National Level -- Martin Raw
Overview of Tobacco Treatment Provisions at a National Level -- Martin RawGlobal Bridges
 
Women and Smoking -- Ivana Croghan, Ph.D., Mayo Clinic
Women and Smoking -- Ivana Croghan, Ph.D., Mayo ClinicWomen and Smoking -- Ivana Croghan, Ph.D., Mayo Clinic
Women and Smoking -- Ivana Croghan, Ph.D., Mayo ClinicGlobal Bridges
 

Mehr von Global Bridges (16)

How you and your project can benefits from using the Global Bridges website
How you and your project can benefits from using the Global Bridges websiteHow you and your project can benefits from using the Global Bridges website
How you and your project can benefits from using the Global Bridges website
 
Presentation on Tobacco Control: District Gujranwala progress and achievemen...
Presentation on Tobacco Control: District Gujranwala progress and achievemen...Presentation on Tobacco Control: District Gujranwala progress and achievemen...
Presentation on Tobacco Control: District Gujranwala progress and achievemen...
 
Webinar: Waterpipe use from the Middle East to Western Countries
Webinar: Waterpipe use from the Middle East to Western CountriesWebinar: Waterpipe use from the Middle East to Western Countries
Webinar: Waterpipe use from the Middle East to Western Countries
 
Dr. Bianco: Humo de segunda mano y riesgos cardiovasculares
Dr. Bianco: Humo de segunda mano y riesgos cardiovascularesDr. Bianco: Humo de segunda mano y riesgos cardiovasculares
Dr. Bianco: Humo de segunda mano y riesgos cardiovasculares
 
Going mobile: the potential of mHealth for tobacco dependence treatment
Going mobile: the potential of mHealth for tobacco dependence treatmentGoing mobile: the potential of mHealth for tobacco dependence treatment
Going mobile: the potential of mHealth for tobacco dependence treatment
 
WEBINAR: Secondhand Smoke: The Science and Big Tobacco's Smokescreen
WEBINAR: Secondhand Smoke: The Science and Big Tobacco's SmokescreenWEBINAR: Secondhand Smoke: The Science and Big Tobacco's Smokescreen
WEBINAR: Secondhand Smoke: The Science and Big Tobacco's Smokescreen
 
Myocardial infarction and sudden cardiac death in olmsted 10 19_11
Myocardial infarction and sudden cardiac death in olmsted 10 19_11Myocardial infarction and sudden cardiac death in olmsted 10 19_11
Myocardial infarction and sudden cardiac death in olmsted 10 19_11
 
Global Bridges: Pharmacotherapy for Tobacco Dependence
Global Bridges: Pharmacotherapy for Tobacco DependenceGlobal Bridges: Pharmacotherapy for Tobacco Dependence
Global Bridges: Pharmacotherapy for Tobacco Dependence
 
Global Bridges: Farmacoterapia para la dependencia del tabaco (español)
Global Bridges: Farmacoterapia para la dependencia del tabaco (español)Global Bridges: Farmacoterapia para la dependencia del tabaco (español)
Global Bridges: Farmacoterapia para la dependencia del tabaco (español)
 
Pharmacotherapy for Tobacco Dependence -- Richard D. Hurt, M.D., Mayo Clinic
Pharmacotherapy for Tobacco Dependence -- Richard D. Hurt, M.D., Mayo ClinicPharmacotherapy for Tobacco Dependence -- Richard D. Hurt, M.D., Mayo Clinic
Pharmacotherapy for Tobacco Dependence -- Richard D. Hurt, M.D., Mayo Clinic
 
Challenges in Expanding the Role of Health Care Providers and Delivering Trea...
Challenges in Expanding the Role of Health Care Providers and Delivering Trea...Challenges in Expanding the Role of Health Care Providers and Delivering Trea...
Challenges in Expanding the Role of Health Care Providers and Delivering Trea...
 
Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...
Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...
Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...
 
Role of Health Care Systems and Providers in Changing Tobacco Dependence Trea...
Role of Health Care Systems and Providers in Changing Tobacco Dependence Trea...Role of Health Care Systems and Providers in Changing Tobacco Dependence Trea...
Role of Health Care Systems and Providers in Changing Tobacco Dependence Trea...
 
Tobacco Dependence Treatment Training -- J. Taylor Hays, M.D.
Tobacco Dependence Treatment Training -- J. Taylor Hays, M.D.Tobacco Dependence Treatment Training -- J. Taylor Hays, M.D.
Tobacco Dependence Treatment Training -- J. Taylor Hays, M.D.
 
Overview of Tobacco Treatment Provisions at a National Level -- Martin Raw
Overview of Tobacco Treatment Provisions at a National Level -- Martin RawOverview of Tobacco Treatment Provisions at a National Level -- Martin Raw
Overview of Tobacco Treatment Provisions at a National Level -- Martin Raw
 
Women and Smoking -- Ivana Croghan, Ph.D., Mayo Clinic
Women and Smoking -- Ivana Croghan, Ph.D., Mayo ClinicWomen and Smoking -- Ivana Croghan, Ph.D., Mayo Clinic
Women and Smoking -- Ivana Croghan, Ph.D., Mayo Clinic
 

Kürzlich hochgeladen

TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...rightmanforbloodline
 
supply cas 5449-12-7 BMK glycidic acid(powder) in stock EU pick-up
supply cas 5449-12-7 BMK glycidic acid(powder) in stock EU pick-upsupply cas 5449-12-7 BMK glycidic acid(powder) in stock EU pick-up
supply cas 5449-12-7 BMK glycidic acid(powder) in stock EU pick-upSherrylee83
 
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 QuinolineUnit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 QuinolineAarishRathnam1
 
TEST BANK For Nursing Leadership, Management, and Professional Practice for t...
TEST BANK For Nursing Leadership, Management, and Professional Practice for t...TEST BANK For Nursing Leadership, Management, and Professional Practice for t...
TEST BANK For Nursing Leadership, Management, and Professional Practice for t...rightmanforbloodline
 
Storage of Blood Components- equipments, effects of improper storage, transpo...
Storage of Blood Components- equipments, effects of improper storage, transpo...Storage of Blood Components- equipments, effects of improper storage, transpo...
Storage of Blood Components- equipments, effects of improper storage, transpo...DrShinyKajal
 
parliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdfparliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdfDr. Nasir Mustafa
 
Histopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseasesHistopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseasesPHARMA IQ EDUCATION
 
ESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failureESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failuremahiavy26
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATROKanhu Charan
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptxclaviclebrown44
 
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTJOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTThomas Onyango Kirengo
 
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...JRRolfNeuqelet
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifierNidhi Joshi
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?bkling
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUELMKARTHIKEMMANUEL
 
How to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialHow to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialSherrylee83
 
Top 10 Most Beautiful Chinese Pornstars List 2024
Top 10 Most Beautiful Chinese Pornstars List 2024Top 10 Most Beautiful Chinese Pornstars List 2024
Top 10 Most Beautiful Chinese Pornstars List 2024locantocallgirl01
 
Forensic medicine MCQ for early learners
Forensic medicine MCQ for early learnersForensic medicine MCQ for early learners
Forensic medicine MCQ for early learnersAlaguPandi5
 
Stereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptxStereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptxAkanshaBhatnagar7
 
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7grandmotherprocess99
 

Kürzlich hochgeladen (20)

TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
 
supply cas 5449-12-7 BMK glycidic acid(powder) in stock EU pick-up
supply cas 5449-12-7 BMK glycidic acid(powder) in stock EU pick-upsupply cas 5449-12-7 BMK glycidic acid(powder) in stock EU pick-up
supply cas 5449-12-7 BMK glycidic acid(powder) in stock EU pick-up
 
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 QuinolineUnit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
 
TEST BANK For Nursing Leadership, Management, and Professional Practice for t...
TEST BANK For Nursing Leadership, Management, and Professional Practice for t...TEST BANK For Nursing Leadership, Management, and Professional Practice for t...
TEST BANK For Nursing Leadership, Management, and Professional Practice for t...
 
Storage of Blood Components- equipments, effects of improper storage, transpo...
Storage of Blood Components- equipments, effects of improper storage, transpo...Storage of Blood Components- equipments, effects of improper storage, transpo...
Storage of Blood Components- equipments, effects of improper storage, transpo...
 
parliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdfparliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdf
 
Histopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseasesHistopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseases
 
ESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failureESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failure
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTJOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
 
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
How to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialHow to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw material
 
Top 10 Most Beautiful Chinese Pornstars List 2024
Top 10 Most Beautiful Chinese Pornstars List 2024Top 10 Most Beautiful Chinese Pornstars List 2024
Top 10 Most Beautiful Chinese Pornstars List 2024
 
Forensic medicine MCQ for early learners
Forensic medicine MCQ for early learnersForensic medicine MCQ for early learners
Forensic medicine MCQ for early learners
 
Stereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptxStereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptx
 
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
 

Challenges in Expanding the Role of Health Care Providers and Delivering Treatment in Africa -- Lekan Ayo-Yusuf, D.D.S., M.P.H., Ph.D.

  • 1. Global Bridges Afro Region Lekan Ayo-Yusuf, DDS, MPH, PhD 15th WCTOH Preconference Workshop March 19, 2012
  • 2. Context: Weak tobacco control in Africa
  • 3. OBJECTIVE 1 To create and mobilize a global network of HCPs and organizations dedicated to advancing effective tobacco dependence treatment and advocating for effective tobacco control policy
  • 4. Network membership  The following 27countries are From a base of 14, over 360 represented: Tunisia (175 trained) Morocco Algeria members joined Libya Egypt over 15 months! Cape Verde Mauritania Mali Niger Chad Sudan Eritrea Senegal Djibouti Burkina via existing Faso The Gambia Guinea Nigeria Somalia Ghana Ethiopia Guinea-Bissau Côte Central African health networks d'Ivoire Cameroon Republic Sierra Leone Liberia Togo Benin Uganda Equatorial Gabon Congo Kenya Tobacco use Guinea DR Congo Rwanda prevalence estimates through training Burundi Seychelles São Tomé Tanzania No Data Malawi and Príncipe workshops Comoros <10% Angola Zambia 10-19% Mozambique through RFA for Zimbabwe Madagascar Africa >=20% Namibia Botswana Mauritius ACS tobacco South Africa Swaziland control masters Lesotho programme
  • 5. Collaborations with other organizations 1. National Council Against Smoking (NCAS), South Africa 2. Public Health Association of South Africa (PHASA) 3. Democratic Nursing Organization of South Africa (DENOSA) 4. Africa Tobacco Control Regional Initiative (ATCRI), Nigeria 5. Africa Tobacco Control Consortium (ATCC), Togo 6. Programme National de Lutte Contre les Toxicomanies et les Substances Toxiques (PNLCT), Democratic Republic of Congo 7. Framework Convention Alliance (FCA), Democratic Republic of Congo 8. Centre for Tobacco Control in Africa (CTCA), Uganda
  • 6. Challenges - 1  Challenging to engage all recruited while running training  Networking to make GB known through key actors in the region and country  No website activities were available for most part of active recruitment period to sustain interest from members  Diversity of culture and language
  • 7. OBJECTIVE 2 To provide state-of-the-art, evidence- based training in treatment and advocacy to network members
  • 8. Policy & Treatment conceptual framework
  • 9. Tobacco cessation training workshops Adapted ATTUD format (Aware → knowledgeable→ Proficient): one day of didactic teaching followed by more interactive skills-building in counselling (motivational interviewing) on day 2 Dates Location # of participants Length of training (hrs) August 16-18 Abadan, Nigeria 25 19 August 23-25 Pretoria, South Africa 29 19 September 23, 26, 27 Lagos, Nigeria 29 20 October 27-29 Lusaka, Zambia 22 20 November 7-8 Kinshasa, DRC 33 12 November 28-30 Johannesburg, South Africa 37 8
  • 10. 1
  • 11. 1
  • 12. 1
  • 13. Challenges - 2  Training has been face-to-face as there is limited technology and in- country capacity to kick start tobacco treatment.  Trainees have expectations to have more training and follow-up visits by facilitators  Health system is currently overburdened and integration of treatment is seen as a challenge in several centers. 1
  • 14. OBJECTIVE 3 To facilitate the implementation of Article 14 in every nation 1
  • 15. News on the advancement of Article 14 Measures to increase demand for treatment –Nigeria: the National Tobacco Control Bill was passed on the 15 March 2011 – still awaiting president’s ascent. –Uganda: Launch of the CTCA - a support from Gates through the WHO –Pilot of feasibility of treatment support to public servants in South Africa – a partnership between the Public Service Admin & Health ministries and major health insurer 1
  • 16. Challenges - 3  Tobacco control is pretty much in infancy in the region  Strong leadership from advocacy organizations and little involvement from health providers makes it more challenging.  Treatment (A14) has not been prioritized due to lack of effective implementation of other key provisions of FCTC – smoke-free laws, taxation and health warnings. 1
  • 17. Challenges - 3  Seniors at work places have not embraced tobacco cessation treatment—no champions  Training non-medical personnel e.g. social workers likely to advance Tx, but has implication for curriculum design  Lack of funding for future work to sustain current advances.  Treatment is not covered by health insurance 1
  • 18. Conclusions  Popularity of the training has increased, even among non- health care professionals involved in tobacco control policy  An instrument to measure the progress of trained HCPs who offer tobacco use treatment to their patients needs to be developed  Build follow-up surveys to measure commitment of HCPs a year after they have received training into our training plan  Network members need to be actively engaged after their recruitment to retain interest  Train only candidates who commit to sending quarterly reports on patient encounters.  Spend more time in engaging network members by posting relevant resource materials on the Global Bridges website and listserv 1
  • 19. Planned meetings  Upcoming 2-day GB tobacco cessation workshops: –Tanzania/Kenya –Enugu, Nigeria  Pre-conference workshops: –WFPHA; Addis Ababa, Ethiopia; 23-27 April 2012 –PHASA Conference; Bloemfontein, South Africa; 5-7 September 2012 1
  • 20. Acknowledgements  Global Bridges for funding the project  Key network partners for been ambassadors of GB and co-facilitating training  UP, UCH,LUTH, UNZ, FCA-DRC and PHASA for hosting the workshops  Network members for their valuable input 2